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Background: Whilst Transcatheter Aortic Valve Implantation (TAVI) using the Edwards Balloon Expandable Valve (EBEV) has been shown to be safe 
and effective, no data is available on long-term valvular function and clinical outcomes. 
Methods: To assess long-term durability, we analysed all patients who underwent successful TAVI who survived >30 days and reached a minimum 
of 3 years follow-up. Clinical follow-up, echocardiographic and Computed Tomography (CT) scanning were performed to assess valvular function. 
Results: 69 patients were analysed at a median of 3.4 years (IQR 3.2-3.8). Longest follow-up was 4.7 years. Baseline risk was high (mean logistic 
EuroSCORE 31±15, Society Thoracic Surgery score 9.0±3.5), mean age 83.4 ± 7.5years. Survival at a median of 3.4 years was 64%. The most 
common mortality cause was respiratory (30%). There was no mortality related to valvular dysfunction or failure. There were no cases of valve failure 
or repeat operation/intervention. Functional class improvements, Aortic Valve Area (AVA) and mean transaortic gradients were maintained long-
term (see table). In the 10 patients who survived >4 years to date, the mean increase in transaortic mean pressure from 12 to 48months was 3.0 
± 2.1mmHG (p<0.05), and mean AVA decrease of 0.23 ± 0.16cm2 (p<0.05). In 11 patients who underwent CT follow-up, no evidence of structural 
deterioration, fracture or recoil were detected. 
Baseline 1 year 2 years 3 years
NYHA Class † 3.0±0.56 1.3±0.56 1.3±0.48 1.4±0.56
AVA, (cm2) † 0.59±0.16 1.50±0.34 1.46±0.36 1.42±0.27
AVMG, mmHG † 45.2±4.7 11.4±5.6 12.8±4.9 12.6 ±5.0
NYHA=New York Heart Association functional class, AVA 
= Aortic Valve Area, AVMG=Aortic Valve Mean Gradient, 
† mean ± SD
Conclusions: TAVI with the EBEV shows durability to over 4 years with no evidence of structural failure.
